Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease

BACKGROUND: Rapidly progressive forms of Alzheimer’s disease (rpAD) are increasingly recognized and may have a prevalence of up to 30% of patients among all patients with Alzheimer’s disease (AD). However, insights about risk factors, underlying pathophysiological processes, and clinical characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Herden, Janne Marieke, Hermann, Peter, Schmidt, Isabel, Dittmar, Kathrin, Canaslan, Sezgi, Weglage, Luise, Nuhn, Sabine, Volpers, Corinna, Schlung, Astrid, Goebel, Stefan, Kück, Fabian, Villar-Piqué, Anna, Schmidt, Christian, Wedekind, Dirk, Zerr, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249304/
https://www.ncbi.nlm.nih.gov/pubmed/37291640
http://dx.doi.org/10.1186/s13195-023-01249-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249304/
https://www.ncbi.nlm.nih.gov/pubmed/37291640
http://dx.doi.org/10.1186/s13195-023-01249-y

Ejemplares similares